SCG Therapy opened its new cell therapy manufacturing facility and research and development center in Singapore, the company announced on July 20, 2023, to pioneer Singapore’s Manufacturing 2030 Vision, according to a company press release. The new facility is set to utilize and extend SCG's capabilities in advanced cell therapy manufacturing and off-the-shelf human-induced Pluripotent Stem Cell (iPSC) technology. Source: Biopharm International 31/7/23